US Patent Issued to King's College London on April 21 for "Dopaminergic imaging to predict treatment response in mental illness" (British Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,608,794, issued on April 21, was assigned to King's College London (London).

"Dopaminergic imaging to predict treatment response in mental illness" was invented by Oliver Howes (London) and Mattia Veronese (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "A neuroimaging-based approach to predict treatment response in mental disorders by acquiring and analysing brain PET dopamine measures from patients. The method uses a short, simplified protocol for [18F]FDOPA brain PET imaging adapted for clinical practice. Individual [18F]FDOPA brain PET data are then quantified with a fully-automated analysis pipeline to extract information on the dopamine fun...